Novel treatment strategies in chronic lymphocytic leukemia

This publication has 30 references indexed in Scilit:

• CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia.
  2000
• Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial.
  2000
• Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy
  Leukemia, 2000
• Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies.
  2000
• The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia.
  1999
• Chlorambucil in Indolent Chronic Lymphocytic Leukemia
  New England Journal of Medicine, 1998
• Advances in the biology and treatment of B-cell chronic lymphocytic leukemia.
  1995
• Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
  1993
• Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis.
  1992
• Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
  1988